| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Interlace Medical, Inc. is a Framingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
C C Young is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Dallas, TX. To find more information about C C Young, please visit www.ccyoung.org
Providence Health & Services is a non-profit, Catholic health care system operating multiple hospitals across eight states, with headquarters in Renton, Washington.
future oncology is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.